期刊: LANCET HAEMATOLOGY, 2022; 9 (9)
Background Multiple myeloma accounted for 176 404 (14%) of 1 278 362 the incidence cases leukaemia, lymphoma, and multiple myeloma in 2020. Identifyin......
期刊: LANCET HAEMATOLOGY, 2022; 9 (6)
Background Adults with acute myeloid leukaemia have unsatisfactory dinical outcomes and rates of complete remission. Venetodax combined with azacytidi......
期刊: LANCET HAEMATOLOGY, 2022; 9 (7)
Background A novel, engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX (FIX) protein (BBM-H901) has been ......
期刊: LANCET HAEMATOLOGY, 2021; 8 (4)
Background Primary immune thrombocytopenia is an autoimmune bleeding disorder. Preclinical reports suggest that the sialidase inhibitor oseltamivir in......
期刊: LANCET HAEMATOLOGY, 2020; 7 (3)
Pregnancy-associated pulmonary embolism is one of the leading causes of maternal mortality. Diagnosis of pulmonary embolism in pregnancy is challengin......
期刊: LANCET HAEMATOLOGY, 2020; 7 (5)
Background Intravenous daratumumab for treatment of patients with multiple myeloma involves a lengthy infusion that affects quality of life, and infus......
期刊: LANCET HAEMATOLOGY, 2020; 7 (7)
Background Sickle cell disease is highly prevalent in sub-Saharan Africa, where it accounts for substantial morbidity and mortality. Newborn screening......